DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Akash Bijlani

Akash Bijlani

Aptar Digital Health

Paper: Impact of the Aptar Digital Health (ADH) respiratory platform on adult asthma healthcare cost

Download Paper

Akash Bijlani is currently the Director of Global Market Access at Aptar Digital Health. My main mission is to expand digital therapeutic (DTx) patient access globally. In my current role, I am responsible for: i) determining evidence gaps (clinical, economic, and operational), implementing plans to fill these gaps, and to support market access; ii) aligning with global health technology assessment (HTA) organizations, key opinion leaders (KOLs), clinicians, pharmaceutical and non-pharmaceutical partners, specialty societies, and DTx organizations to create new pathways for DTx patient access globally; iii) working with our in-country partners to obtain DTx coding, coverage, and payment approval to drive adoption of digital products; iv) expanding DTx globally to include disease management.

I hold a Master of Public Health (MPH) in International Health and Development from Tulane University and a Bachelor of Arts (BA) in Sociology from the University of Chicago. Prior to joining Aptar, I was CEO and Founder of my own global health economics and market access consultancy, Strategy Access Solutions, for seven years. In this role, I worked with digital health, artificial intelligence, lab and diagnostic, pharmaceutical, biotechnology and medical device companies to develop evidence, models, and dossiers, and then utilized these to facilitate global market access. Prior to this role, I worked at two medical device companies where I was responsible for global health economics and market access. In previous roles, I was a hospital administrator at three US academic medical centers.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk